2012
DOI: 10.1161/strokeaha.112.673665
|View full text |Cite
|
Sign up to set email alerts
|

Stent-Based Thrombectomy Versus Intravenous Tissue Plasminogen Activator in Patients With Acute Middle Cerebral Artery Occlusion

Abstract: Background and Purpose-Our goal was to compare outcomes of patients with proximal middle cerebral artery occlusions treated with intravenous tissue plasminogen activator (tPA) with those of patients treated with stent-based thrombectomy (SBT). Methods-Patients with proximal middle cerebral artery occlusions included in our prospective stroke registry were identified. Patients presenting with moderate to severe stroke defined as National Institutes of Health Stroke Scale score ≥10 were included. Patients treate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 12 publications
0
13
0
Order By: Relevance
“…According to the inclusion and exclusion criteria, 17 primary studies were finally selected: 2 RCTs, 3 comparative studies (stent retrievers vs. rtPA, Merci ® or another stent) and 12 case series ( table 1 ). The Solitaire TM device was assessed alone in 10 studies (n = 1,267) [21][22][23][24][25][26][27][28][29][30] , Trevo ® in 4 (n = 221) [30][31][32][33] and Revive TM in 1 (n = 10) [34] . One study evaluated both Solitaire TM and Trevo ® stents (n = 43 and n = 26, respectively) [35] , and another study assessed both the Solitaire TM and Revive TM devices (n = 9 and n = 12, respectively) [36] .…”
Section: Search Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…According to the inclusion and exclusion criteria, 17 primary studies were finally selected: 2 RCTs, 3 comparative studies (stent retrievers vs. rtPA, Merci ® or another stent) and 12 case series ( table 1 ). The Solitaire TM device was assessed alone in 10 studies (n = 1,267) [21][22][23][24][25][26][27][28][29][30] , Trevo ® in 4 (n = 221) [30][31][32][33] and Revive TM in 1 (n = 10) [34] . One study evaluated both Solitaire TM and Trevo ® stents (n = 43 and n = 26, respectively) [35] , and another study assessed both the Solitaire TM and Revive TM devices (n = 9 and n = 12, respectively) [36] .…”
Section: Search Resultsmentioning
confidence: 99%
“…The 4 case series included (n = 451) had a weighted mean of asymptomatic haemorrhage rate of 18 ± 8.9% [22,24,28,32] . In patients with basilar artery occlusion, only Möhlenbruch et al [36] reported a single case of asymptomatic haemorrhage.…”
Section: Safety Of Stent Retrieversmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, patient identification by thrombus length, not only the site of occlusion, and solely the use of highly effective stent retrievers seem to be important corner points for successful intraarterial treatment. Once more, registry studies in acute stroke using stent-based thrombectomy also revealed an increase in favorable outcome after 90 days: Leker et al found up to 60 % of patients treated by thrombectomy reaching an mRS of 0 to 2 compared to 37.5 % in patients treated by i. v. thrombolysis [18]. In a recent study a 90-day favorable outcome of even 77 % and a recanalization rate of 90 % could be achieved using the Solitaire ® device [19].…”
Section: Abb 3 Klinisches Ergebnis (Mrs) 90 Tage Nach Schlaganfall Imentioning
confidence: 99%
“…2 Accurate identification of occlusion location also enables candidate selection for mechanical endovascular therapy (MET), which may be offered for large intracranial artery occlusions. [3][4][5] Digital subtraction angiography remains the criterion standard of imaging techniques for precisely determining occlusion location. When MR imaging is used as the first-line technique in patients with acute stroke, 3D-TOF is the recommended MRA sequence for depicting the level of intracranial occlusion.…”
mentioning
confidence: 99%